Evidence Hub

Real-Time Imaging of 177Lu-Labeled Radiopharmaceutical Infusions with a Portable γ-Camera: Pilot Trial Results

J. Oldan, Jennifer A. Schroeder, A. Khandani, H. Collins, J. Pope, R. Huynh, M. Ivanovic, Steven P. Rowe

Journal of Nuclear Medicine Technology, 2026

Abstract

Visual Abstract Recently, it was proposed that follow-up imaging for patients treated with 177Lu-labeled radiopharmaceuticals should be focused on posttherapy SPECT/CT, given the intrinsic γ-photon emitted by 177Lu, suggesting that real-time imaging of radiopharmaceutical infusions using γ-camera technology may be feasible. In this pilot feasibility study, we used a portable γ-camera situated within our theranostics suite to visualize the infusion of 177Lu-labeled radiopharmaceuticals in real time. Methods: Patients were consecutively enrolled between June 5, 2025, and July 17, 2025, with any patient receiving a 177Lu-based radiopharmaceutical infusion at our theranostics center being eligible for inclusion. 177Lu-based radiopharmaceuticals were administered via syringe method. A portable γ-camera was used for dynamic image acquisition. An open-energy window was used to obtain 120 frames at 30 s per frame for a total of 5 or 30 min (to include the entirety of either a 177Lu-PSMA-617 or a 177Lu-DOTATATE infusion, respectively) using a 128 × 128 matrix and a low-energy, high-resolution collimator. Results: Six patients were imaged, and the 177Lu-labeled radiopharmaceutical was visibly confined to the venous system, with measurable time–activity curves, in all patients. No evidence of immediate complication was seen during the imaging of any of the infusions, and no findings suggest an event such as extravasation occurred. Conclusion: Dynamic, real-time imaging of infusions of…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free